Sort
39,280 grants matching “leukemia”
Cell Processing and Storage
$328,310Shelly Heimfeld · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA
The NF-kB signaling system as a regulator of B-cell activation
$328,296Alexander Hoffmann · University Of California, San Diego · R01 · FY2013 · AI
Perinatal immune development and risk of childhood acute lymphoblastic leukemia
$328,290Joseph Leo Wiemels · University Of California, San Francisco · R01 · FY2017 · CA
Bone Pseudoarthrosis Dissected through the Generation of New Mouse Models
$328,244Florent Elefteriou · Vanderbilt University · R01 · FY2012 · AR
Bone Pseudoarthrosis Dissected through the Generation of New Mouse Models
$328,244Florent Elefteriou · Vanderbilt University · R01 · FY2011 · AR
Characterization of a Potential Nuclear Protein Depot
$328,243Wistar Institute · R01 · FY2004 · GM
mTOR-regulated U2AF plasticity and alternative polyadenylation
$328,241Jeongsik Yong · University Of Minnesota · R01 · FY2020 · GM
Project 3: Tumor Antigen Reactive Donor T Cell Immunotherapy
$328,204Samuel Strober · Stanford University · P01 · FY2022 · CA
Molecular Characterization of T-bet's Role in Immunity
$328,200University Of Washington · R01 · FY2004 · AI
DEPSIPEPTIDE: A NOVEL HISTONE DEACYTLASE INHIBITOR IN L
$328,188Ohio State University · R21 · FY2003 · CA
Novel functions of CDK6 in T-cell leukemia progression
$328,143Haizhen Wang · Medical University Of South Carolina · R37 · FY2024 · CA
CD300 receptors regulate efferocytosis, importance in inflammation, cancer and autoimmunity
$328,135John Coligan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Enhancing the Potency and Durability of Immunotherapies
$328,134Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2017 · CA
Targeting Cancer Stem Cells
$328,120Richard J Jones · Johns Hopkins University · P01 · FY2007 · CA
Genetic Analysis of Myeloproliferative Disease
$328,106John K Cowell · Augusta University · R01 · FY2020 · CA
Is Chromosome Therapy Possible for Down Syndrome and Other Karyotypic Imbalances?
$328,083Jeanne Bentley Lawrence · Univ Of Massachusetts Med Sch Worcester · R01 · FY2009 · GM
MKL in megakaryocytopoiesis
$328,079Diane S. Krause · Yale University · R01 · FY2013 · DK
P-1: Targeting Aurora Kinase in Aggressive B-cell non-Hodgkin's Lymphomas
$328,078Daruka Mahadevan · University Of Rochester · P50 · FY2009 · CA
Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML
$328,076Ravindra Majeti · Stanford University · R01 · FY2017 · CA
Role of TGFBI gene in cell proliferation and tumor progression
$328,007Yongliang Zhao · Columbia University Health Sciences · R01 · FY2008 · CA
Tyrosine kinase inhibitors for the treatment of childhood AML
$327,998Sharyn D Baker · St. Jude Children'S Research Hospital · R01 · FY2014 · CA
Structural Biology of AML1 (CBFA2) and AML1-ETO
$327,990University Of Virginia Charlottesville · R01 · FY2005 · CA
METHAMPHETAMINE DEPENDENCE AND THE RISK OF HIV INFECTION
$327,952Haight-Ashbury Free Clinics, Inc. · R01 · FY2001 · DA
DNA REARRANGEMENTS IN MOMULV INDUCED THYMOMAS
$327,941Thomas Jefferson University · R01 · FY2000 · CA
Development of Therapeutic CD59 inhibitor for treating B-cell malignancies
$327,938Xuebin Qin · Temple Univ Of The Commonwealth · R01 · FY2017 · CA